DOCSLIB.ORG

Elektronische Hochschulschriften Der LMU

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Elektronische Hochschulschriften Der LMU Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München A non-canonical pathway for aromatic amino acid biosynthesis in haloarchaea Identification and function of essential genes Miriam (Mirit) Kolog Gulko Tel-Aviv 2010 Erklärung Diese Dissertation wurde im Sinne von §13 Abs. 3 bzw. 4 der Promotionsordnung vom 29. Januar 1998 von Herrn Prof. Dr. Dieter Oesterhelt betreut. Ehrenwörtliche Versicherung Diese Dissertationn wurde selbständig, ohne unerlaubte Hilfe erarbeitet. München, am ........................... .......................................... Miriam (Mirit) Kolog Gulko Dissertation eingereicht am: 25/03/2010 1. Gutacher: Prof. Dr. Dieter Oesterhelt 2. Guttacher: Prof. Dr. Nediljko Budisa Mündliche Prüfung am: 07/06/2010 Ricardo, as always, for all things- past, present and yet to come "The outcome of any serious research can only be to make two questions grow where only one grew before" Thorstein Veblen, (1857-1929) U.S. economist and sociologist Table of contents 1 Abbreviations ....................................................................................................... 1 2 Acknowledgments ................................................................................................ 3 3 Summary ............................................................................................................... 5 4 Introduction .......................................................................................................... 7 4.1 The three domains of life ............................................................................... 7 4.2 Diversity and unity ......................................................................................... 8 4.3 Metabolism of halophilic archaea .................................................................. 9 4.3.1 Shikimate pathway of aromatic amino acids (AroAAs) biosynthesis ................. 11 4.3.2 Pathway reconstruction from genomic data ...................................................... 13 4.3.2.1 Shikimate pathway in Methanocaldococcus and Methanococcus ............ 15 4.3.2.2 The Shikimate pathway in Haloarchaea.................................................... 16 4.3.2.3 Postulating de novo pathway in Haloarchaea ........................................... 21 4.4 Enzyme classification .................................................................................. 22 4.4.1 Aldolases EC 4.1.2.13 ........................................................................................ 22 4.4.2 Dehydroquinate synthase EC 4.6.1.3 ................................................................. 24 4.4.3 dehydroquinate dehydratase EC 4.2.1.10 .......................................................... 24 4.5 Microarray analysis ...................................................................................... 25 4.6 Objectives .................................................................................................... 27 5 Materials and Methods ...................................................................................... 28 5.1 Materials ...................................................................................................... 28 5.1.1 Chemicals .......................................................................................................... 28 5.1.2 Kits and Enzymes ............................................................................................... 28 5.1.3 Media, Buffers and Stock solutions .................................................................... 29 5.1.3.1 Media ........................................................................................................ 29 5.1.3.2 Buffers ...................................................................................................... 33 5.1.3.3 Antibiotics ................................................................................................. 34 5.1.4 Strains, Vectors and Oligonucleotides ............................................................... 35 5.1.4.1 Strains ....................................................................................................... 35 5.1.4.2 Plasmids .................................................................................................... 36 5.1.4.3 Oligonucleotides ....................................................................................... 37 5.2 Microbiological methods ............................................................................. 37 5.2.1 Cultivation of E. coli .......................................................................................... 37 5.2.2 Cultivation of H. salinarum and N. pharaonis .................................................. 37 5.3 Molecular biological methods ..................................................................... 38 Table of contents 5.3.1 Transformation of E. coli ................................................................................... 38 5.3.1.1 Preparation of chemically-competent cells ............................................... 38 5.3.1.2 Transformation of chemically-competent cells ......................................... 40 5.3.1.3 Transformation of electro-competent cells ............................................... 40 5.3.2 Transformation of H. salinarum ........................................................................ 41 5.3.3 Transformation of N. pharaonis ........................................................................ 42 5.3.3.1 PEG method .............................................................................................. 42 5.3.3.2 Electroporation .......................................................................................... 42 5.3.3.3 Gun particle ............................................................................................... 42 5.3.4 Preparation of genomic DNA from H. salinarum .............................................. 43 5.3.5 Isolation of plasmid DNA from E. coli .............................................................. 43 5.3.6 Agarose gel electrophoresis ............................................................................... 43 5.3.7 Isolation of DNA from preparative agarose gels ............................................... 44 5.3.8 Determination of DNA concentration ................................................................ 45 5.3.9 Sequencing of DNA ............................................................................................ 45 5.3.10 Polymerase chain reaction (PCR) ................................................................. 45 5.3.10.1 Ligation of DNA fragments ...................................................................... 47 5.3.10.2 Digestion of DNA by restriction endonucleases ....................................... 48 5.3.10.3 ORFs OE1472F, OE1475F, OE1477R, and OE2019F from R1 ............... 48 5.3.10.4 Plasmids for gene deletion ........................................................................ 48 5.3.10.4.1 Blue/red screening of transformant colonies ..................................... 51 5.3.10.5 Southern blot analysis ............................................................................... 52 5.3.11 Microarrays ................................................................................................... 53 5.3.11.1 Microarray design ..................................................................................... 53 5.3.11.2 Isolation of total RNA ............................................................................... 53 5.3.11.3 Microarray analysis ................................................................................... 54 5.3.12 RT-PCR ......................................................................................................... 55 5.4 Protein Methods ........................................................................................... 56 5.4.1 SDS-PAGE of proteins ....................................................................................... 56 5.4.2 Western blot analysis ......................................................................................... 57 5.4.3 Determination of protein concentration ............................................................ 58 5.4.4 EasyXpress protein Synthesis Kit (Qiagen) ....................................................... 58 5.4.5 Expression and purification of OE1472F, OE1475F and OE1477R from R1 ... 58 5.4.6 N-terminal sequencing ....................................................................................... 59 5.4.7 Amino acid analysis ........................................................................................... 59 5.4.8 Activity assays .................................................................................................... 59 5.4.8.1 Aldolase activity using a coupled enzyme assay ...................................... 59 II Table of contents 5.4.8.2 Colorimetric assay of Aldolase ................................................................. 60 5.4.8.3 3-Dehydroquinate dehydratase ................................................................. 60 5.4.8.4 LC-MS ...................................................................................................... 61 5.4.8.5 GC-MS ...................................................................................................... 61 5.5 Synthesis .....................................................................................................
Load more

Recommended publications
  • Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism
    biology Article Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism Ibrahim H. Polat 1,2,3 ,Míriam Tarrado-Castellarnau 1,4 , Rohit Bharat 1, Jordi Perarnau 1 , Adrian Benito 1,5 , Roldán Cortés 1, Philippe Sabatier 2 and Marta Cascante 1,4,* 1 Department of Biochemistry and Molecular Biomedicine and Institute of Biomedicine (IBUB), Faculty of Biology, Universitat de Barcelona, Av Diagonal 643, 08028 Barcelona, Spain; [email protected] (I.H.P.); [email protected] (M.T.-C.); [email protected] (R.B.); [email protected] (J.P.); [email protected] (A.B.); [email protected] (R.C.) 2 Equipe Environnement et Prédiction de la Santé des Populations, Laboratoire TIMC (UMR 5525), CHU de Grenoble, Université Grenoble Alpes, 38700 CEDEX La Tronche, France; [email protected] 3 Department of Medicine, Hematology/Oncology, Goethe-University Frankfurt, 60590 Frankfurt, Germany 4 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), 28001 Madrid, Spain 5 Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London W12 0NN, UK * Correspondence: [email protected] Simple Summary: Cancer cells alter their metabolism to maintain their high need for energy, produce Citation: Polat, I.H.; enough macromolecules for biosynthesis, and preserve their redox status. The investigation of Tarrado-Castellarnau, M.; Bharat, R.; cancer cell-specific metabolic alterations has vital importance to identify targets to be exploited for Perarnau, J.; Benito, A.; Cortés, R.; therapeutic development. The pentose phosphate pathway (PPP) is often highly activated in tumor Sabatier, P.; Cascante, M.
    [Show full text]
  • Part One Amino Acids As Building Blocks
    Part One Amino Acids as Building Blocks Amino Acids, Peptides and Proteins in Organic Chemistry. Vol.3 – Building Blocks, Catalysis and Coupling Chemistry. Edited by Andrew B. Hughes Copyright Ó 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim ISBN: 978-3-527-32102-5 j3 1 Amino Acid Biosynthesis Emily J. Parker and Andrew J. Pratt 1.1 Introduction The ribosomal synthesis of proteins utilizes a family of 20 a-amino acids that are universally coded by the translation machinery; in addition, two further a-amino acids, selenocysteine and pyrrolysine, are now believed to be incorporated into proteins via ribosomal synthesis in some organisms. More than 300 other amino acid residues have been identified in proteins, but most are of restricted distribution and produced via post-translational modification of the ubiquitous protein amino acids [1]. The ribosomally encoded a-amino acids described here ultimately derive from a-keto acids by a process corresponding to reductive amination. The most important biosynthetic distinction relates to whether appropriate carbon skeletons are pre-existing in basic metabolism or whether they have to be synthesized de novo and this division underpins the structure of this chapter. There are a small number of a-keto acids ubiquitously found in core metabolism, notably pyruvate (and a related 3-phosphoglycerate derivative from glycolysis), together with two components of the tricarboxylic acid cycle (TCA), oxaloacetate and a-ketoglutarate (a-KG). These building blocks ultimately provide the carbon skeletons for unbranched a-amino acids of three, four, and five carbons, respectively. a-Amino acids with shorter (glycine) or longer (lysine and pyrrolysine) straight chains are made by alternative pathways depending on the available raw materials.
    [Show full text]
  • Generated by SRI International Pathway Tools Version 25.0, Authors S
    An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_000238675-HmpCyc: Bacillus smithii 7_3_47FAA Cellular Overview Connections between pathways are omitted for legibility.
    [Show full text]
  • Lecture 7 - the Calvin Cycle and the Pentose Phosphate Pathway
    Lecture 7 - The Calvin Cycle and the Pentose Phosphate Pathway Chem 454: Regulatory Mechanisms in Biochemistry University of Wisconsin-Eau Claire 1 Introduction The Calvin cycle Text The dark reactions of photosynthesis in green plants Reduces carbon from CO2 to hexose (C6H12O6) Requires ATP for free energy and NADPH as a reducing agent. 2 2 Introduction NADH versus Text NADPH 3 3 Introduction The Pentose Phosphate Pathway Used in all organisms Glucose is oxidized and decarboxylated to produce reduced NADPH Used for the synthesis and degradation of pentoses Shares reactions with the Calvin cycle 4 4 1. The Calvin Cycle Source of carbon is CO2 Text Takes place in the stroma of the chloroplasts Comprises three stages Fixation of CO2 by ribulose 1,5-bisphosphate to form two 3-phosphoglycerate molecules Reduction of 3-phosphoglycerate to produce hexose sugars Regeneration of ribulose 1,5-bisphosphate 5 5 1. Calvin Cycle Three stages 6 6 1.1 Stage I: Fixation Incorporation of CO2 into 3-phosphoglycerate 7 7 1.1 Stage I: Fixation Rubisco: Ribulose 1,5- bisphosphate carboxylase/ oxygenase 8 8 1.1 Stage I: Fixation Active site contains a divalent metal ion 9 9 1.2 Rubisco Oxygenase Activity Rubisco also catalyzes a wasteful oxygenase reaction: 10 10 1.3 State II: Formation of Hexoses Reactions similar to those of gluconeogenesis But they take place in the chloroplasts And use NADPH instead of NADH 11 11 1.3 State III: Regeneration of Ribulose 1,5-Bisphosphosphate Involves a sequence of transketolase and aldolase reactions. 12 12 1.3 State III:
    [Show full text]
  • Characterization of the Human O-Phosphoethanolamine Phospholyase, an Unconventional Pyridoxal Phosphate- Dependent -Lyase
    Department of Pharmacy Laboratories of Biochemistry and Molecular Biology PhD Program in Biochemistry and Molecular Biology XXVII cycle Characterization of the human O-phosphoethanolamine phospholyase, an unconventional pyridoxal phosphate- dependent -lyase Coordinator: Prof. Andrea Mozzarelli Tutor: Prof. Alessio Peracchi PhD student: DAVIDE SCHIROLI 2012-2014 1 INDEX: Chapter 1: A subfamily of PLP-dependent enzymes specialized in handling terminal amines Abstract……………………………………………...pg.10 Introduction………………………………………….pg.11 -Nomenclature issues: subgroup-II aminotransferases, class-III ami- notransferases or -aminotransferases?..........................................pg.13 Chemical peculiarities of the reactions catalyzed by AT-II enzymes………………………………………pg.18 - Equilibria in -amine transaminase reactions……………………...pg.18 - Specificity and dual-specificity issues…………………………….…pg.22 Structural peculiarities of AT-II enzymes………...pg.23 - AT-II vs. AT-I enzymes. Comparing the overall structures………..pg.23 - AT-II vs. AT-I. Comparing the PLP-binding sites…………………...pg.25 - The substrate binding site: a gateway system in -KG-specific AT-II transaminases……………………………………………………………pg.31 - The substrate binding site: P and O pockets in pyruvate-specific AT-II transaminases………………………………………………………...….pg.35 - An overview of substrate specificity in AT-II transaminases………pg.42 2 AT-II enzymes that are not aminotransferases……….. …………………………………………………….....pg.43 Inferences on the evolution of AT-II enzymes………… ………………………………………………………..pg.47 Conclusions……………..…………………………..pg.53
    [Show full text]
  • Supplementary Materials
    Supplementary Materials Figure S1. Differentially abundant spots between the mid-log phase cells grown on xylan or xylose. Red and blue circles denote spots with increased and decreased abundance respectively in the xylan growth condition. The identities of the circled spots are summarized in Table 3. Figure S2. Differentially abundant spots between the stationary phase cells grown on xylan or xylose. Red and blue circles denote spots with increased and decreased abundance respectively in the xylan growth condition. The identities of the circled spots are summarized in Table 4. S2 Table S1. Summary of the non-polysaccharide degrading proteins identified in the B. proteoclasticus cytosol by 2DE/MALDI-TOF. Protein Locus Location Score pI kDa Pep. Cov. Amino Acid Biosynthesis Acetylornithine aminotransferase, ArgD Bpr_I1809 C 1.7 × 10−4 5.1 43.9 11 34% Aspartate/tyrosine/aromatic aminotransferase Bpr_I2631 C 3.0 × 10−14 4.7 43.8 15 46% Aspartate-semialdehyde dehydrogenase, Asd Bpr_I1664 C 7.6 × 10−18 5.5 40.1 17 50% Branched-chain amino acid aminotransferase, IlvE Bpr_I1650 C 2.4 × 10−12 5.2 39.2 13 32% Cysteine synthase, CysK Bpr_I1089 C 1.9 × 10−13 5.0 32.3 18 72% Diaminopimelate dehydrogenase Bpr_I0298 C 9.6 × 10−16 5.6 35.8 16 49% Dihydrodipicolinate reductase, DapB Bpr_I2453 C 2.7 × 10−6 4.9 27.0 9 46% Glu/Leu/Phe/Val dehydrogenase Bpr_I2129 C 1.2 × 10−30 5.4 48.6 31 64% Imidazole glycerol phosphate synthase Bpr_I1240 C 8.0 × 10−3 4.7 22.5 8 44% glutamine amidotransferase subunit Ketol-acid reductoisomerase, IlvC Bpr_I1657 C 3.8 × 10−16
    [Show full text]
  • RESPIRATION Pentose Phosphate Pathway Or Hexose Monophosphate Pathway
    RESPIRATION Pentose Phosphate Pathway or Hexose Monophosphate Pathway Pentose phosphate pathway or hexose monophosphate pathway (HMP pathway) is the other common pathway to break down glucose to pyruvate and operates in both aerobic and anaerobic conditions. This pathway produces NADPH, which carries chemical energy in the form of reducing power and is used almost universally as the reductant in anabolic (energy utilization) pathways (e.g., fatty acid biosynthesis, cholesterol biosynthesis, nucleotide biosynthesis) and detoxification pathways (e.g., reduction of oxidized glutathione, cytochrome P450 monooxygenases). Also, the pentose phosphate pathway generates pentose sugar ribose and its derivatives, which are necessary for the biosynthesis of nucleic acids (DNA and RNA) as well as ATP, NADH, FAD, and coenzyme A. In this way, though the pentose phosphate pathway may be a source of energy in many microorganisms, it is more often of greater importance in various biosynthetic pathways. Pentose phosphate pathway consists of two phases: the oxidative phase and the non-oxidative phase. Oxidative Phase: The oxidative phase of the pentose phosphate pathway initiates with the conversion of glucose 6- phosphate to 6-Phosphogluconate. NADP+ is the electron acceptor yielding NADPH during this reaction. 6-Phosphogluconate, a six-carbon sugar, is then oxidativelydecarboxylated to yield ribulose 5-phosphate, a five-carbon sugar. NADP+ is again the electron acceptor yielding NADPH. In the final step of oxidative phase, there is isomerisation of ribulose 5-phosphatc to ribose 5- phosphate by phosphopentose isomerase and the conversion of ribulose 5-phosphate into its epimerxylulose 5-phosphate by phosphopentose epimerase for the transketolase reaction in non- oxidative phase.
    [Show full text]
  • Transaldolase B of Escherichia Coli K-12: Cloning of Its Gene, Talb, and Characterization of the Enzyme from Recombinant Strains
    JOURNAL OF BACTERIOLOGY, Oct. 1995, p. 5930–5936 Vol. 177, No. 20 0021-9193/95/$04.0010 Copyright q 1995, American Society for Microbiology Transaldolase B of Escherichia coli K-12: Cloning of Its Gene, talB, and Characterization of the Enzyme from Recombinant Strains GEORG A. SPRENGER,* ULRICH SCHO¨ RKEN, GERDA SPRENGER, AND HERMANN SAHM Institut fu¨r Biotechnologie 1, Forschungszentrum Ju¨lich GmbH, D-52425 Ju¨lich, Germany Received 7 June 1995/Accepted 7 August 1995 A previously recognized open reading frame (T. Yura, H. Mori, H. Nagai, T. Nagata, A. Ishihama, N. Fujita, K. Isono, K. Mizobuchi, and A. Nakata, Nucleic Acids Res. 20:3305–3308) from the 0.2-min region of the Escherichia coli K-12 chromosome is shown to encode a functional transaldolase activity. After cloning of the gene onto high-copy-number vectors, transaldolase B (D-sedoheptulose-7-phosphate:D-glyceraldehyde-3-phos- phate dihydroxyacetone transferase; EC 2.2.1.2) was overexpressed up to 12.7 U mg of protein21 compared with less than 0.1 U mg of protein21 in wild-type homogenates. The enzyme was purified from recombinant E. coli K-12 cells by successive ammonium sulfate precipitations (45 to 80% and subsequently 55 to 70%) and two anion-exchange chromatography steps (Q-Sepharose FF, Fractogel EMD-DEAE tentacle column; yield, 130 mg of protein from 12 g of cell wet weight) and afforded an apparently homogeneous protein band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with a subunit size of 35,000 6 1,000 Da. As the enzyme had a molecular mass of 70,000 Da by gel filtration, transaldolase B is likely to form a homodimer.
    [Show full text]
  • B Number Gene Name Mrna Intensity Mrna
    sample) total list predicted B number Gene name assignment mRNA present mRNA intensity Gene description Protein detected - Membrane protein membrane sample detected (total list) Proteins detected - Functional category # of tryptic peptides # of tryptic peptides # of tryptic peptides detected (membrane b0002 thrA 13624 P 39 P 18 P(m) 2 aspartokinase I, homoserine dehydrogenase I Metabolism of small molecules b0003 thrB 6781 P 9 P 3 0 homoserine kinase Metabolism of small molecules b0004 thrC 15039 P 18 P 10 0 threonine synthase Metabolism of small molecules b0008 talB 20561 P 20 P 13 0 transaldolase B Metabolism of small molecules chaperone Hsp70; DNA biosynthesis; autoregulated heat shock b0014 dnaK 13283 P 32 P 23 0 proteins Cell processes b0015 dnaJ 4492 P 13 P 4 P(m) 1 chaperone with DnaK; heat shock protein Cell processes b0029 lytB 1331 P 16 P 2 0 control of stringent response; involved in penicillin tolerance Global functions b0032 carA 9312 P 14 P 8 0 carbamoyl-phosphate synthetase, glutamine (small) subunit Metabolism of small molecules b0033 carB 7656 P 48 P 17 0 carbamoyl-phosphate synthase large subunit Metabolism of small molecules b0048 folA 1588 P 7 P 1 0 dihydrofolate reductase type I; trimethoprim resistance Metabolism of small molecules peptidyl-prolyl cis-trans isomerase (PPIase), involved in maturation of b0053 surA 3825 P 19 P 4 P(m) 1 GenProt outer membrane proteins (1st module) Cell processes b0054 imp 2737 P 42 P 5 P(m) 5 GenProt organic solvent tolerance Cell processes b0071 leuD 4770 P 10 P 9 0 isopropylmalate
    [Show full text]
  • PENTOSE PHOSPHATE PATHWAY — Restricted for Students Enrolled in MCB102, UC Berkeley, Spring 2008 ONLY
    Metabolism Lecture 5 — PENTOSE PHOSPHATE PATHWAY — Restricted for students enrolled in MCB102, UC Berkeley, Spring 2008 ONLY Bryan Krantz: University of California, Berkeley MCB 102, Spring 2008, Metabolism Lecture 5 Reading: Ch. 14 of Principles of Biochemistry, “Glycolysis, Gluconeogenesis, & Pentose Phosphate Pathway.” PENTOSE PHOSPHATE PATHWAY This pathway produces ribose from glucose, and it also generates 2 NADPH. Two Phases: [1] Oxidative Phase & [2] Non-oxidative Phase + + Glucose 6-Phosphate + 2 NADP + H2O Ribose 5-Phosphate + 2 NADPH + CO2 + 2H ● What are pentoses? Why do we need them? ◦ DNA & RNA ◦ Cofactors in enzymes ● Where do we get them? Diet and from glucose (and other sugars) via the Pentose Phosphate Pathway. ● Is the Pentose Phosphate Pathway just about making ribose sugars from glucose? (1) Important for biosynthetic pathways using NADPH, and (2) a high cytosolic reducing potential from NADPH is sometimes required to advert oxidative damage by radicals, e.g., ● - ● O2 and H—O Metabolism Lecture 5 — PENTOSE PHOSPHATE PATHWAY — Restricted for students enrolled in MCB102, UC Berkeley, Spring 2008 ONLY Two Phases of the Pentose Pathway Metabolism Lecture 5 — PENTOSE PHOSPHATE PATHWAY — Restricted for students enrolled in MCB102, UC Berkeley, Spring 2008 ONLY NADPH vs. NADH Metabolism Lecture 5 — PENTOSE PHOSPHATE PATHWAY — Restricted for students enrolled in MCB102, UC Berkeley, Spring 2008 ONLY Oxidative Phase: Glucose-6-P Ribose-5-P Glucose 6-phosphate dehydrogenase. First enzymatic step in oxidative phase, converting NADP+ to NADPH. Glucose 6-phosphate + NADP+ 6-Phosphoglucono-δ-lactone + NADPH + H+ Mechanism. Oxidation reaction of C1 position. Hydride transfer to the NADP+, forming a lactone, which is an intra-molecular ester.
    [Show full text]
  • Synthesis and Cell Survival Under Stress Conditions . the PPP
    Pentose phosphate pathway Significance of Pentose Phosphate Pathway To generate reducing equivalents, in the form of NADPH, which is needed for fatty acid synthesis and cell survival under stress conditions . To provide the cell with ribose-5-phosphate (R5P) for the synthesis of the nucleotides and nucleic acids. No ATP is generated in this pathway. So glucose can be metabolized through this pathway even when energy requirement is low. Location of the pathway • The enzymes are located in the cytosol. The tissues such as liver, adipose tissue, adrenal gland, erythrocytes, testes & lactating mammary gland, are highly active in the oxidative phase of HMP shunt. Rapidly dividing cells have a high activity of the non-oxidative phase. *It is called the pentose phosphate shunt because the pathway allows for carbon atoms from glucose 6-phosphate to take a shunt before they proceed down the glycolytic pathway. The PPP comprises two irreversible oxidative reactions followed by a series of reversible interconversions. The PPP is thus divided into two biochemical branches: An oxidative and a non-oxidative branch. The oxidative branch converts glucose 6-phosphate (G6P) into ribulose-5-phosphate (Ru5P), CO2 and NADPH. NADPH is vital to maintain the reduction-oxidation (redox) balance under stress conditions and allows cells to proliferate rapidly. The non-oxidative branch yields the glycolytic intermediates fructose 6-phosphate (F6P), glyceraldehyde 3-phosphate (G3P) and sedoheptulose sugars, resulting in the production of sugar phosphate precursors for amino acid synthesis and ribose-5-phosphate (R5P), which is essential for nucleic acid synthesis. Oxidative Phase of the Pentose Phosphate Pathway Glucose 6-phosphate is oxidized to 6-phosphoglucono-δ-lactone to generate one molecule of NADPH.
    [Show full text]
  • Supplementary Information
    Supplementary information (a) (b) Figure S1. Resistant (a) and sensitive (b) gene scores plotted against subsystems involved in cell regulation. The small circles represent the individual hits and the large circles represent the mean of each subsystem. Each individual score signifies the mean of 12 trials – three biological and four technical. The p-value was calculated as a two-tailed t-test and significance was determined using the Benjamini-Hochberg procedure; false discovery rate was selected to be 0.1. Plots constructed using Pathway Tools, Omics Dashboard. Figure S2. Connectivity map displaying the predicted functional associations between the silver-resistant gene hits; disconnected gene hits not shown. The thicknesses of the lines indicate the degree of confidence prediction for the given interaction, based on fusion, co-occurrence, experimental and co-expression data. Figure produced using STRING (version 10.5) and a medium confidence score (approximate probability) of 0.4. Figure S3. Connectivity map displaying the predicted functional associations between the silver-sensitive gene hits; disconnected gene hits not shown. The thicknesses of the lines indicate the degree of confidence prediction for the given interaction, based on fusion, co-occurrence, experimental and co-expression data. Figure produced using STRING (version 10.5) and a medium confidence score (approximate probability) of 0.4. Figure S4. Metabolic overview of the pathways in Escherichia coli. The pathways involved in silver-resistance are coloured according to respective normalized score. Each individual score represents the mean of 12 trials – three biological and four technical. Amino acid – upward pointing triangle, carbohydrate – square, proteins – diamond, purines – vertical ellipse, cofactor – downward pointing triangle, tRNA – tee, and other – circle.
    [Show full text]